Josep M Domingo-domenech
ASSOCIATE PROFESSOR
Pathology
Icahn School of Medicine
United States of America
Biography
Multi-Disciplinary Training Areas Cancer Biology [CAB], Genetics and Genomic Sciences [GGS] Education MD, University of Barcelona Residency Medical Oncology, Hospital Clinic Barcelona Master Healthcare Services Management, ESADE Bussiness School PhD, University of Barcelona Postdoctoral, Columbia University
Research Interest
Cancer, Cancer Genetics, Drug Design and Discovery, Drug Resistance, Gene Regulation, Metastasis, Oncogenes, Prostate
Publications
-
Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, etal (2011) Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy. The Journal of urology Vol: 186.
-
Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, etal (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer cell Vol: 22.
-
Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sánchez-Carbayo M, etal (2013) A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. The American journal of pathology Vol: 182.
-
Galsky MD, Domingo-Domenech J (2013) Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches. Clinical advances in hematology & oncology : H&O Vol: 11.
-
Vidal SJ, Rodriguez-Bravo V, Galsky M, Cordon-Cardo C, Domingo-Domenech J (2013) Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene.
-
Vidal S, Quinn A, de la Iglesia J, Bonal D, Rodriguez-Bravo V, etal (2014)Isolation of cancer stem cells from human prostate cancer samples. J Vis Exp Vol: 14.
-
Vidal S, Rodriguez-Bravo V, Quinn A, Rodriguez-Barrueco R, Lujambio A, etal (2015) A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. Cancer Cell Vol: 27.
-
Williams E, Rodriguez-Bravo V, Chippada-Venkata U, de la Iglesia J, Gong Y, etal (2015) Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. J Vis Exp Vol: 20.
